Inmagene Biopharmaceuticals

company

About

It is a leading biotech company focused on immunology-related therapeutic areas.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$100M
Industries
Biopharma,Biotechnology,Health Care
Number Of Employee
51 - 100
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
Inmagene Biopharmaceuticals has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2021 Series C $100M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Inmagene Biopharmaceuticals is funded by 1 investors. Kunlun Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Kunlun Fund Series C